Cover Image
Market Research Report

Cardiac Catheters - Medical Devices Pipeline Assessment, 2018

Published by GlobalData Product code 345367
Published Content info 320 Pages
Delivery time: 1-2 business days
Price
Back to Top
Cardiac Catheters - Medical Devices Pipeline Assessment, 2018
Published: June 4, 2018 Content info: 320 Pages
Description

GlobalData's Medical Devices sector report, "Cardiac Catheters - Medical Devices Pipeline Assessment, 2018" provides an overview of Cardiac Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0567EPD

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 8
  • 1.2 List of Figures 11

2 Introduction 12

  • 2.1 Cardiac Catheters Overview 12

3 Products under Development 13

  • 3.1 Cardiac Catheters - Pipeline Products by Stage of Development 13
  • 3.2 Cardiac Catheters - Pipeline Products by Segment 14
  • 3.3 Cardiac Catheters - Pipeline Products by Territory 15
  • 3.4 Cardiac Catheters - Pipeline Products by Regulatory Path 16
  • 3.5 Cardiac Catheters - Pipeline Products by Estimated Approval Date 17
  • 3.6 Cardiac Catheters - Ongoing Clinical Trials 18

4 Cardiac Catheters - Pipeline Products under Development by Companies 19

  • 4.1 Cardiac Catheters Companies - Pipeline Products by Stage of Development 19
  • 4.2 Cardiac Catheters - Pipeline Products by Stage of Development 21

5 Cardiac Catheters Companies and Product Overview 23

  • 5.1 3DT Holdings LLC Company Overview 23
  • 5.2 AngioDynamics Inc Company Overview 25
  • 5.3 Avantec Vascular Corp Company Overview 26
  • 5.4 Avinger Inc Company Overview 27
  • 5.5 Balch Hill Medical Group Company Overview 28
  • 5.6 Boston Scientific Corp Company Overview 29
  • 5.7 Boston TransTec LLC Company Overview 30
  • 5.8 Cardiovascular Systems Inc Company Overview 31
  • 5.9 Cordis Corp Company Overview 34
  • 5.10 Delft University of Technology Company Overview 37
  • 5.11 Deliverance Ltd. Company Overview 38
  • 5.12 Edwards Lifesciences Corp Company Overview 39
  • 5.13 Emory University Company Overview 45
  • 5.14 EP Ltd Company Overview 46
  • 5.15 Georgia Institute of Technology Company Overview 47
  • 5.16 Hadasit Medical Research Services and Development Ltd Company Overview 48
  • 5.17 Harvard University Company Overview 49
  • 5.18 iVascular SLU Company Overview 50
  • 5.19 MaRVis Technologies GmbH Company Overview 52
  • 5.20 Mayo Clinic Company Overview 53
  • 5.21 Medical Device Investments, Inc. Company Overview 55
  • 5.22 Medtronic plc Company Overview 57
  • 5.23 Merit Medical Systems Inc Company Overview 58
  • 5.24 MicroPort Scientific Corp Company Overview 60
  • 5.25 Neovasc Inc Company Overview 62
  • 5.26 NeuroInterventional Therapeutics, Inc. Company Overview 63
  • 5.27 Nipro Corp Company Overview 64
  • 5.28 Northwestern University Company Overview 65
  • 5.29 Ohio State University Wexner Medical Center Company Overview 66
  • 5.30 Perseus Biomed Ltd Company Overview 69
  • 5.31 Pi-Cardia Ltd Company Overview 70
  • 5.32 QualiMed Innovative Medizinprodukte GmbH Company Overview 74
  • 5.33 Revamp Medical Ltd Company Overview 75
  • 5.34 Rhythm Solutions Company Overview 78
  • 5.35 Sonix Therapeutics Company Overview 79
  • 5.36 Therix Medical, Inc. (Inactive) Company Overview 80
  • 5.37 Three Rivers Cardiovascular Systems Inc Company Overview 81
  • 5.38 TransCardiac Therapeutics, LLC Company Overview 82
  • 5.39 U.S. Stem Cell Inc Company Overview 83
  • 5.40 University of California Davis Company Overview 85
  • 5.41 University of California San Francisco Company Overview 86
  • 5.42 University of Limerick Company Overview 88
  • 5.43 University of Montreal Company Overview 89
  • 5.44 Vanderbilt University Company Overview 90
  • 5.45 Vascular Concepts Ltd Company Overview 91
  • 5.46 Volcano Corp Company Overview 92
  • 5.47 Voyage Medical (Inactive) Company Overview 93
  • 5.48 Weill Cornell Medical College Company Overview 94

6 Cardiac Catheters- Recent Developments 95

  • 6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 95
  • 6.2 May 21, 2018: Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference 97
  • 6.3 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 99
  • 6.4 May 16, 2018: Pi-Cardia Initiates First-in-Human Study With Novel Non-Implant Based Treatment of Aortic Stenosis 99
  • 6.5 May 16, 2018: Teleflex to Introduce the New TrapLiner Catheter in Europe and Showcase the Arrow AC3 Optimus Intra-Aortic Balloon Pump at the European Association for Percutaneous Cardiovascular Interventions Course 2018 100
  • 6.6 May 15, 2018: Asahi Intecc Group announces financial results and presentation materials for the 3rd Quarter of the fiscal year ending June 2018. 101
  • 6.7 May 14, 2018: Autologous Stem Cell Therapy May Hold Key to Regeneration 101
  • 6.8 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 102
  • 6.9 May 11, 2018: BioCardia Reports First Quarter 2018 Financial Results And Business Highlights 102
  • 6.10 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives 102
  • 6.11 May 10, 2018: Neovasc Announces Results for the First Quarter 2018 103
  • 6.12 May 09, 2018: U.S. Stem Cell Reports First Quarter Results 107
  • 6.13 May 09, 2018: ICU Medical Announces First Quarter 2018 Results 107
  • 6.14 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 108
  • 6.15 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical 108
  • 6.16 May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year 109
  • 6.17 May 03, 2018: Teleflex Reports First Quarter 2018 Results 110
  • 6.18 May 02, 2018: Cardiovascular Systems Reports Fiscal 2018 Third-Quarter Financial Results 112
  • 6.19 May 02, 2018: Endologix Announces First Quarter 2018 Financial Results 114
  • 6.20 May 02, 2018: Endologix Names John Onopchenko As Chief Executive Officer 115
  • 6.21 Apr 26, 2018: Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018 116
  • 6.22 Apr 26, 2018: Stryker reports first quarter 2018 operating results 117
  • 6.23 Apr 26, 2018: Getinge publishes Interim Report for January-March 2018 118
  • 6.24 Apr 26, 2018: Utah Medical Products Reports Financial Performance for First Quarter 2018 118
  • 6.25 Apr 26, 2018: Osprey Medical: Quarterly Cash Flow Report 122
  • 6.26 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results 125
  • 6.27 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 126
  • 6.28 Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%) 128
  • 6.29 Apr 25, 2018: Xianjian Technology Receives the Most Attention from Institutional Investors 129
  • 6.30 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 129
  • 6.31 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 131
  • 6.32 Apr 18, 2018: Abbott Reports First-Quarter 2018 Results 131
  • 6.33 Apr 17, 2018: Johnson & Johnson Reports 2018 First-Quarter Results 134
  • 6.34 Apr 16, 2018: USRM Reports 2017 Financial Results 136
  • 6.35 Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018 137
  • 6.36 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 137
  • 6.37 Apr 02, 2018: Beacon Tip Catheters Return to U.S. and Canadian Markets 138
  • 6.38 Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 138
  • 6.39 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results 139
  • 6.40 Mar 28, 2018: Vascular Insights Announces New Chief Financial Officer 140
  • 6.41 Mar 28, 2018: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017 141
  • 6.42 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 144
  • 6.43 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 146
  • 6.44 Mar 21, 2018: BioCardia Announces Fourth Quarter 2017 Financial Results 146
  • 6.45 Mar 20, 2018: LiDCO Group: End of third party UK Distribution agreement 147
  • 6.46 Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson 148
  • 6.47 Mar 16, 2018: Vascular Insights Announces A New Lead To The Global Commercial Team 148
  • 6.48 Mar 08, 2018: Baylis Medical wins Best Managed Companies award 149
  • 6.49 Mar 01, 2018: ICU Medical Announces Fourth Quarter and Fiscal Year 2017 Results 149
  • 6.50 Feb 28, 2018: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2017; Merit Meets Range of 2017 Guidance; Gives 2018 Guidance 150
  • 6.51 Feb 26, 2018: Osprey Medical Preliminary Final Report and Consolidated Financial Statements 151
  • 6.52 Feb 23, 2018: Holy Cross Hospital is One of the First to Use New DIAMONDBACK 360 CORONARY OAS Technology for Treatment of Coronary Artery Disease 154
  • 6.53 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance 154
  • 6.54 Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017 157
  • 6.55 Feb 21, 2018: Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results 157
  • 6.56 Feb 21, 2018: Endologix Announces Resignation Of John McDermott As Chief Executive Officer 159
  • 6.57 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 159
  • 6.58 Feb 08, 2018: MicroPort Signs Strategic Agreement with Neptunus Biotechnology 159
  • 6.59 Feb 07, 2018: Cardiovascular Systems Reports Fiscal 2018 Second-Quarter Financial Results 160
  • 6.60 Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy 161
  • 6.61 Feb 02, 2018: Cardiovascular Systems Appoints Jeff Points as Chief Financial Officer 162
  • 6.62 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 163
  • 6.63 Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year 165
  • 6.64 Feb 01, 2018: Baxter Reports 2017 Fourth-Quarter and Full-Year Results 165
  • 6.65 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 168

7 Appendix 316

  • 7.1 Methodology 316
  • 7.2 About GlobalData 319
  • 7.3 Contact Us 319
  • 7.4 Disclaimer 319

List of Tables

1.1 List of Tables

  • Table 1: Cardiac Catheters - Pipeline Products by Stage of Development 14
  • Table 2: Cardiac Catheters - Pipeline Products by Segment 15
  • Table 3: Cardiac Catheters - Pipeline Products by Territory 16
  • Table 4: Cardiac Catheters - Pipeline Products by Regulatory Path 17
  • Table 5: Cardiac Catheters - Pipeline Products by Estimated Approval Date 18
  • Table 6: Cardiac Catheters - Ongoing Clinical Trials 19
  • Table 7: Cardiac Catheters Companies - Pipeline Products by Stage of Development 20
  • Table 8: Cardiac Catheters - Pipeline Products by Stage of Development 22
  • Table 9: 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 10: Hypothermia Catheter - Product Status 24
  • Table 11: Hypothermia Catheter - Product Description 24
  • Table 12: Sizing Valvuloplasty Conductance Balloon Catheter - Product Status 25
  • Table 13: Sizing Valvuloplasty Conductance Balloon Catheter - Product Description 25
  • Table 14: Transseptal Access Catheter - Product Status 25
  • Table 15: Transseptal Access Catheter - Product Description 25
  • Table 16: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 17: Coronary Angio Catheter - Product Status 26
  • Table 18: Coronary Angio Catheter - Product Description 26
  • Table 19: Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 20: Specialty Coronary Catheter - Product Status 27
  • Table 21: Specialty Coronary Catheter - Product Description 27
  • Table 22: Avinger Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 23: Ocelaris CAD - Product Status 28
  • Table 24: Ocelaris CAD - Product Description 28
  • Table 25: Balch Hill Medical Group Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 26: PrecisionThread - Product Status 29
  • Table 27: PrecisionThread - Product Description 29
  • Table 28: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 29: Crossing Catheter - Product Status 30
  • Table 30: Crossing Catheter - Product Description 30
  • Table 31: Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 32: Viper Catheter - Product Status 31
  • Table 33: Viper Catheter - Product Description 31
  • Table 34: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 35: Diamondback 360 Coronary Orbital Atherectomy System - Product Status 32
  • Table 36: Diamondback 360 Coronary Orbital Atherectomy System - Product Description 32
  • Table 37: Cardiovascular Systems Inc - Ongoing Clinical Trials Overview 33
  • Table 38: Diamondback 360 Coronary Orbital Atherectomy System - Comparison of Orbital Versus Rotational Atherectomy Effects on Coronary Microcirculation in Percutaneous Coronary Intervention (PCI) 34
  • Table 39: Diamondback 360 Coronary Orbital Atherectomy System - Evaluation of Treatment Strategies for Severe CalcIfic Coronary Arteries: Orbital Atherectomy versus Conventional Angioplasty Technique Prior to Implantation of Drug-eluting Stents: The ECLIPSE Trial 34
  • Table 40: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 41: NOGA Guided Myostar Injection Catheter - Product Status 35
  • Table 42: NOGA Guided Myostar Injection Catheter - Product Description 35
  • Table 43: Cordis Corp - Ongoing Clinical Trials Overview 36
  • Table 44: NOGA Guided Myostar Injection Catheter - A Phase I, Open-label Study of the Effects of Percutaneous Administration of an Extracellular Matrix Hydrogel, VentriGel, Following Myocardial Infarction 37
  • Table 45: NOGA Guided Myostar Injection Catheter - A Phase I/II, Randomized, Placebo-controlled Study of the Safety and Efficacy of Transendocardial Injection of Autologous Human Cells (Mesenchymal or the Combination of MSC and Cardiac Stem Cells) in Patients with Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction 37
  • Table 46: Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 47: Multi-Steerable Catheter - Product Status 38
  • Table 48: Multi-Steerable Catheter - Product Description 38
  • Table 49: Deliverance Ltd. Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 50: Laparoscopic Braided Sealer And Filler Catheter - Product Status 39
  • Table 51: Laparoscopic Braided Sealer And Filler Catheter - Product Description 39
  • Table 52: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 53: CCOmbo Catheter - Product Status 40
  • Table 54: CCOmbo Catheter - Product Description 41
  • Table 55: CCOmbo RVEDV Catheter - Product Status 41
  • Table 56: CCOmbo RVEDV Catheter - Product Description 41
  • Table 57: CCOmbo RVEDV/VIP Catheter - Product Status 42
  • Table 58: CCOmbo RVEDV/VIP Catheter - Product Description 42
  • Table 59: CCOmbo VIP Catheter - Product Status 42
  • Table 60: CCOmbo VIP Catheter - Product Description 43
  • Table 61: Continuous Cardiac Output RVEDV/VIP Catheter - Product Status 43
  • Table 62: Continuous Cardiac Output RVEDV/VIP Catheter - Product Description 43
  • Table 63: Continuous Cardiac Output VIP Catheter - Product Status 44
  • Table 64: Continuous Cardiac Output VIP Catheter - Product Description 44
  • Table 65: Small French Oximetry Catheter - Product Status 44
  • Table 66: Small French Oximetry Catheter - Product Description 45
  • Table 67: Emory University Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 68: Antegrade Catheter - Product Status 46
  • Table 69: Antegrade Catheter - Product Description 46
  • Table 70: EP Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 71: Laser Based Thermodilution Catheter - Product Status 47
  • Table 72: Laser Based Thermodilution Catheter - Product Description 47
  • Table 73: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 74: MRI Catheter - Product Status 48
  • Table 75: MRI Catheter - Product Description 48
  • Table 76: Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 77: Double Lumen PCI Guiding Catheter - Product Status 49
  • Table 78: Double Lumen PCI Guiding Catheter - Product Description 49
  • Table 79: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 80: Motion Compensated Catheter System - Product Status 50
  • Table 81: Motion Compensated Catheter System - Product Description 50
  • Table 82: iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 83: Navitian Micro Catheter - Product Status 51
  • Table 84: Navitian Micro Catheter - Product Description 51
  • Table 85: Sergeant Support Catheter - Product Status 52
  • Table 86: Sergeant Support Catheter - Product Description 52
  • Table 87: MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 88: MaRVis Catheter - Product Status 53
  • Table 89: MaRVis Catheter - Product Description 53
  • Table 90: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 91: Acoustic Catheter - Product Status 54
  • Table 92: Acoustic Catheter - Product Description 54
  • Table 93: Aortic Valve Guide Catheter - Product Status 55
  • Table 94: Aortic Valve Guide Catheter - Product Description 55
  • Table 95: Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 96: Cardiac/Carotid Aspirating Balloon Catheter - Product Status 56
  • Table 97: Cardiac/Carotid Aspirating Balloon Catheter - Product Description 56
  • Table 98: Ostial Stent Placement Catheter - Product Status 57
  • Table 99: Ostial Stent Placement Catheter - Product Description 57
  • Table 100: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 101: Low Profile FFR Micro-catheter - Product Status 58
  • Table 102: Low Profile FFR Micro-catheter - Product Description 58
  • Table 103: Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 104: Crossing Support Guide Catheter - Product Status 59
  • Table 105: Crossing Support Guide Catheter - Product Description 59
  • Table 106: Lamsano - Product Status 60
  • Table 107: Lamsano - Product Description 60
  • Table 108: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 109: Catheter - Coronary Ischemia - Product Status 61
  • Table 110: Catheter - Coronary Ischemia - Product Description 61
  • Table 111: Intramyocardial Injection Catheter - Product Status 62
  • Table 112: Intramyocardial Injection Catheter - Product Description 62
  • Table 113: Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 114: Ostial Flare - Product Status 63
  • Table 115: Ostial Flare - Product Description 63
  • Table 116: NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 117: DVT Intervention System - Product Status 64
  • Table 118: DVT Intervention System - Product Description 64
  • Table 119: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 120: Micro Catheter - Product Status 65
  • Table 121: Micro Catheter - Product Description 65
  • Table 122: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 123: Triple Balloon Occlusion/ Infusion Catheter - Product Status 66
  • Table 124: Triple Balloon Occlusion/ Infusion Catheter - Product Description 66
  • Table 125: Ohio State University Wexner Medical Center Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 126: Cardiovascular Catheter - Congestive Heart Failure - Product Status 67
  • Table 127: Cardiovascular Catheter - Congestive Heart Failure - Product Description 67
  • Table 128: Ohio State University Wexner Medical Center - Ongoing Clinical Trials Overview 68
  • Table 129: Cardiovascular Catheter - Congestive Heart Failure - Safety and Feasibility of Cardiovascular Catheter in Treatment of Patients with Congestive Heart Failure 69
  • Table 130: Perseus Biomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 131: Intravascular Catheter - Chronic Disease - Product Status 70
  • Table 132: Intravascular Catheter - Chronic Disease - Product Description 70
  • Table 133: Pi-Cardia Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 134: Leaflex Catheter System - Product Status 71
  • Table 135: Leaflex Catheter System - Product Description 71
  • Table 136: Second Generation Leaflex Performer Catheter - Product Status 72
  • Table 137: Second Generation Leaflex Performer Catheter - Product Description 72
  • Table 138: Pi-Cardia Ltd - Ongoing Clinical Trials Overview 73
  • Table 139: Leaflex Catheter System - First-in-human Study of Leaflex Performer Catheter System in the Treatment of Aortic Stenosis 74
  • Table 140: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 141: Biodegradable Catheter - Product Status 75
  • Table 142: Biodegradable Catheter - Product Description 75
  • Table 143: Revamp Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 144: Doraya Catheter - Product Status 76
  • Table 145: Doraya Catheter - Product Description 76
  • Table 146: Revamp Medical Ltd - Ongoing Clinical Trials Overview 77
  • Table 147: Doraya Catheter - First in Human Study of the Doraya Catheter for the Treatment of AHF Patients 78
  • Table 148: Rhythm Solutions Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 149: Cardiovascular Catheter - Gene Therapy - Product Status 79
  • Table 150: Cardiovascular Catheter - Gene Therapy - Product Description 79
  • Table 151: Sonix Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 152: Percutaneous Ultrasonic Drug Delivery System - Product Status 80
  • Table 153: Percutaneous Ultrasonic Drug Delivery System - Product Description 80
  • Table 154: Therix Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 155: Cardiac Catheter - Product Status 81
  • Table 156: Cardiac Catheter - Product Description 81

List of Figures

1.2 List of Figures

  • Figure 1: Cardiac Catheters - Pipeline Products by Stage of Development 14
  • Figure 2: Cardiac Catheters - Pipeline Products by Segment 15
  • Figure 3: Cardiac Catheters - Pipeline Products by Territory 16
  • Figure 4: Cardiac Catheters - Pipeline Products by Regulatory Path 17
  • Figure 5: Cardiac Catheters - Pipeline Products by Estimated Approval Date 18
  • Figure 6: Cardiac Catheters - Ongoing Clinical Trials 19
Back to Top